Net profit of Hester Biosciences rose 76.22% to Rs 14.45 crore in the quarter ended September 2025 as against Rs 8.20 crore during the previous quarter ended September 2024. Sales declined 15.20% to Rs 70.97 crore in the quarter ended September 2025 as against Rs 83.69 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 70.97 | 83.69 | -15 |
| OPM % | 16.51 | 22.89 | - |
| PBDT | 21.39 | 16.07 | 33 |
| PBT | 17.04 | 11.87 | 44 |
| NP | 14.45 | 8.20 | 76 |